Klaria Pharma Holding AB
6FN
Company Profile
Business description
Klaria Pharma Holding AB is a Swedish pharmaceutical company that develops rapid-acting products. By combining patented technology of a film that attaches to the oral mucosa and pharmaceuticals, the company has developed a drug distribution concept with many benefits and potential uses. Its patented drug delivery platform consists of an alginate-based polymer film that enables the absorption of a product’s active substance through the oral mucosa.
Contact
Virdings Alle 2
Uppsala754 50
CHET: +41 84464299
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
4
Stocks News & Analysis
stocks
10 best US growth stocks to buy for the long term
The stocks of these high-quality growth companies look undervalued today.
stocks
Higher fair value for overvalued ASX tech share
Underlying secular growth stronger than we thought.
stocks
Nvidia: Collaboration with Intel might bring some goodwill with the US
We doubt the $5 billion is meaningful enough to force Nvidia to use Intel, either for core products or even for the chips in collaboration.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,102.10 | 11.70 | 0.13% |
CAC 40 | 7,832.95 | 20.64 | -0.26% |
DAX 40 | 23,483.16 | 156.25 | -0.66% |
Dow JONES (US) | 46,315.27 | 172.85 | 0.37% |
FTSE 100 | 9,221.39 | 4.72 | 0.05% |
HKSE | 26,344.14 | 200.96 | -0.76% |
NASDAQ | 22,631.48 | 160.75 | 0.72% |
Nikkei 225 | 45,493.66 | 447.85 | 0.99% |
NZX 50 Index | 13,141.54 | 90.12 | -0.68% |
S&P 500 | 6,664.36 | 32.40 | 0.49% |
S&P/ASX 200 | 8,810.90 | 11.40 | 0.13% |
SSE Composite Index | 3,828.58 | 8.49 | 0.22% |